FDA Approves DOXAZOSIN — Aurobindo Pharma Limited

Aurobindo Pharma Limited announced the approval of an Abbreviated New Drug Application for doxazosin mesylate tablets to be marketed immediately. This expansion into the oral generic segment signals a strategic move that is likely to intensify competition and increase profitability within the alpha-blocker market.